Aligos therapeutics to present at the svb securities global biopharma conference

South san francisco, calif., feb. 10, 2023 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in nash and viral diseases, today announced that lawrence m. blatt, ph.d., mba, chairman and ceo of aligos, will present at the virtual svb securities global biopharma conference on wednesday, february 15, 2023 at 5:00 p.m. et.
ALGS Ratings Summary
ALGS Quant Ranking